- $11.61bn
- $11.25bn
- $1.19bn
Annual cashflow statement for Penumbra, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.3 | 2.62 | -2 | 91 | 14 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 43.1 | 71.3 | 42.1 | 77.3 | 171 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -51.2 | -66.7 | -122 | -79.1 | -23.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -33.2 | 9.5 | -55.7 | 97.3 | 168 |
| Capital Expenditures | -24.8 | -21.2 | -19.3 | -15.2 | -21.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -79.4 | -0.555 | 74.1 | -0.863 | 98.8 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -104 | -21.7 | 54.8 | -16.1 | 77.6 |
| Financing Cash Flow Items | -13 | -16.1 | -8.18 | -2.23 | -1.52 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 135 | 0.836 | 11.6 | 16.2 | -87 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.11 | -10.3 | 10.5 | 97.6 | 157 |